Evidence summary and stakeholder input
The following is a summary of the findings from the evidence gathering activities and stakeholder consultations undertaken to inform development of the Roadmap. For more information on the development of the Roadmap see the About page.
Key priority areas
Strengthen clinical guidance to reduce unwarranted variations in treatments for people with pancreatic cancer